ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $5,000 | -28.6% | 14,823 | 0.0% | 0.00% | – |
Q1 2017 | $7,000 | +16.7% | 14,823 | +24.2% | 0.00% | – |
Q4 2016 | $6,000 | 0.0% | 11,935 | 0.0% | 0.00% | – |
Q3 2016 | $6,000 | -50.0% | 11,935 | -1.6% | 0.00% | – |
Q2 2016 | $12,000 | +50.0% | 12,124 | 0.0% | 0.00% | – |
Q1 2016 | $8,000 | – | 12,124 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 396,104 | $400,000 | 0.42% |
Ancora Advisors LLC | 50,865 | $51,000 | 0.01% |
Acrospire Investment Management LLC | 5,200 | $5,000 | 0.00% |
EAGLE GLOBAL ADVISORS LLC | 145,710 | $146,000 | 0.00% |
A.R.T. Advisors, LLC | 57,954 | $57,000 | 0.00% |
Renaissance Technologies | 876,100 | $876,000 | 0.00% |
PANAGORA ASSET MANAGEMENT INC | 133,846 | $134,000 | 0.00% |
Cutler Group LLC / CA | 11,048 | $11,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 4,600 | $5,000 | 0.00% |
Timber Hill LLC | 10,663 | $11,000 | 0.00% |